Osteoprotegerin: A novel secreted protein involved in the regulation of bone density

Cell

Volumn 89, Issue 2, 1997, Pages 309-319

  Simonet, W S ^a   Lacey, D L ^a   Dunstan, C R ^a   Kelley, M ^a   Chang, M S ^a   Luthy R ^a   Nguyen, H Q ^a   Wooden, S ^a   Bennett, L ^a   Boone, T ^a   Shimamoto, G ^a   DeRose, M ^a   Elliott, R ^a   Colombero, A ^a   Tan, H L ^a   Trall, G ^a   Sullivan, J ^a   Davy, E ^a   Bucay, N ^a   Renshaw Gegg, L ^a   Hughes, T M ^a   Hill, D ^a   Pattison, W ^a   Campbell, P ^a   Sander, S ^a   Van, G ^a   Tarpley, J ^a   Derby, P ^a   Lee, R ^a   Boyle, W J ^a   more..

^a AMGEN INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GLYCOPROTEIN; OSTEOPROTEGRIN; PAMIDRONIC ACID; RECOMBINANT PROTEIN; TUMOR NECROSIS FACTOR RECEPTOR; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; BONE DENSITY; BONE MASS; CELL DIFFERENTIATION; CONTROLLED STUDY; FEMALE; HUMAN; MOUSE; NONHUMAN; OSTEOCLAST; OSTEOLYSIS; OSTEOPOROSIS; OVARIECTOMY; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN SECRETION; RAT;

ANIMALIA; MUS MUSCULUS;

EID: 0031005576     PISSN: 00928674     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0092-8674(00)80209-3     Document Type: Article

References (38)

1. Adams, M.D., Kelley, J.M., Gocayne, J.D., Dubnick, M., Polymeropoulos, M.H., Xiao, H., Merril, C.R., Wu, A., Olde, B., Moreno, R.F., et al. (1991). Complementary DNA sequencing: expressed sequence tags and human genome project. Science 252, 1651-1656.
2. Ahn, J., Lüdecke, J.-H., Lindow, S., Horton, W.A., Lee, B., Wagner, M.J., Horsthemke, B., and Wells, D.E. (1995). Cloning of the putative tumor supressor gene for hereditary multiple exostoses. Nature Genet. 11, 137-143.
3. Austyn, J.M., and Gordon, S. (1981). F4/80, a monoclonal antibody directed specifically against the mouse macrophage. Eur. J. Immunol. 11, 805-815.
4. Bertolini, D.R., Nedwin, G.E., Bringman, T.S., Smith, D.D., and Mundy, G.R. (1986). Stimulation of bone resorption and inhibition of bone formation in vitro by human tumor necrosis factor. Nature 319, 516-518.
5. Boyle, W.J., Smeal, T., Defize, L.H.K., Angel, P., Woodgett, J.R., Karin, M., and Hunter, T. (1991). Activation of protein kinase C decreases phosphorylation of c-Jun at sites that negatively regulate its DNA-binding activity. Cell 64, 573-584.
6. Brinster, R.L., Chen, H.Y., Trumbauer, M.E., Yagle, M.K., and Palmiter, R.D. (1985). Factors affecting the efficiency of introducing foreign DNA into mice by microinjecting eggs. Proc. Natl. Acad. Sci. USA 82, 4438-4442.
7. Byrn, R.A., Mordenti, J., Lucas, C., Smith, D., Marsters, S.A., Johnson, J.S., Cossum, P., Chamow, S.M., Wurm, F.M., Gregory, T., Groopman, J.E., and Capon, D.J. (1990). Biological properties of a CD4 immunoadhesin. Nature 34, 667-670.
8. Christiansen, C., Christensen, M.S., McNair, P., Hagen, C., Stocklund, K.E., and Transbol, I. (1980). Prevention of early post-menopausal bone loss: controlled 2-year study in 315 normal females. Eur. J. Clin. Invest. 10, 273-279.
9. DeClerk, Y.A., Yean, T.-D., Lu, H.S., Ting, J., and Langley, K.E. (1991). Inhibition of autoproteolytic activation of interstitial procollagenase by recombinant metalloproteinase inhibitor MI/TIMP-2. J. Biol. Chem. 266, 3893-3899.
10. Ey, P.L., Prowse, S.J., and Jenkin, C.R. (1978). Isolation of pure IgG1, IgG2a, and IgG2b immunoglobulins from mouse serum using protein A-Sepharose. Biochemistry 15, 429-436.
11. Grigoriades, A.E., Wang, Z.Q., Cecchini, M.G., Hofstetter, W., Felix, R., Fleisch, H.A., and Wagner, E.F. (1994). c-Fos: a key regulator of osteoclast-macrophage lineage determination and bone remodeling. Science 266, 443-448.
12. Heng, H.H.Q., Squire, J., and Tsui, L.-C. (1992). High resolution mapping of mammalian genes by in situ hybridization to free chromatin. Proc. Natl. Acad. Sci. USA 89, 9509-9513.
13. Hughes, D.P.M., and Crispe, I.N. (1995). A naturally occuring soluble isoform of murine Fas generated by alternativesplicing. J. Exp. Med. 182, 1395-1401.
14. Jähner, D., and Hunter, T. (1991). The ras-related gene rhoB is an immediate-early gene inducible by v-Fps, epidermal growth factor, and platelet-derived growth factor in rat fibroblasts. Mol. Cell. Biol. 11, 3682-3690.
15. Kalu, D.N., Liu, C.C., Hardin, R.R., and Hollis, B.W. (1989). The aged rat model of ovarian deficiency bone loss. Endocrinology 124, 7-16.
16. Kamps, M.P., and Sefton, B.M. (1988). Identification of multiple novel polypeptide substrates of the v-src, v-yes, v-fps, v-ros, and v-erb-B oncogenic tyrosine protein kinases utilizing antisera against phosphotyrosine. Oncogene 2, 305-315.
17. Kohno, T., Brewer, M.T., Baker, S.L., Schwartz, P.E., King, M.W., Hale, K.K., Squires, C.H., Thompson, B.C., and Vannice, J.L. (1990). A second tumor necrosis factor receptor gene can shed a naturally occuring tumor necrosis factor inhibitor. Proc. Natl. Acad. Sci. USA 87, 8331-8335.
18. Lacey, D.L., Erdmann, J.M., Teitelbaum, S.L., Tan, H.-L., Ohara, J., and Shioi, A. (1995). Interleukin 4, interferon-γ, and prostaglandin E impact the osteoclastic cell-forming potential of murine bone marrow macrophages. Endocrinology 136, 2367-2376.
19. Lüthy, R.I., Xenarios, I., and Bucher, P. (1994). Improving the sensitivity of the sequence profile method. Protein Sci. 3, 139-146.
20. Marks, S.C., Jr. (1989). Osteoclast biology, lessons from mammalian mutations. Am. J. Med. Genet. 34, 43-53.
21. Mundy, G.R. (1993a). Factors which stimulate bone growth in vivo. Growth Reg. 3, 124-128.
22. Mundy, G.R. (1993b). Cytokines and local factors which affect osteoclast function. Int. J. Cell Clon. 10, 215-222.
23. Nijweide, P.J., Burger, E.H., and Feyen, J.H.M. (1986). Cells of the bone: proliferation, differentiation and hormonal regulation. Physiol. Rev. 66, 855-886.
24. Pearson, W.R. (1990). Rapid and sensitive sequence comparison with FASTP and FASTA. Meth. Enzymol. 183, 63-98.
25. Rodan, G.A., and Martin, T.J. (1981). Role of osteoblasts in hormonal control of bone resorptions. A hypothesis. Calcif. Tissues Int. 33, 349-351.
26. Schreiber, M., Rajarathnam, K., and McFadden, G. (1996). Myxoma virus T2 protein, a tumor necrosis factor (TNF) receptor homolog, is secreted by a monomer and dimer that each bind rabbit TNFα, but the dimer is a more potent TNF inhibitor. J. Biol. Chem. 271, 13333-13341.
27. Sietsema, W.K., Ebetino, F.H., Salvagno, A.M., and Bevan, J.A. (1989). Antiresorptive dose-response relationships across three generations of bisphosphonates. Drugs Under Exp. Clin. Res. 15, 389-396.
28. Simonet, W.S., Bucay, N., Lauer, S.J., and Taylor, J.M. (1993). A far-downstream hepatocyte-specific control region directs expression of the linked human apolipoprotein E and C-I genes in transgenic mice. J. Biol. Chem. 268, 8221-8229.
29. Simonet, W.S., Hughes, T.M., Nguyen, H.Q., Trebaski, L.D., Danilenko, D.M., and Medlock, E.S. (1994). Long-term impaired neutrophil migration in mice overexpressing human interleukin-8. J. Clin. Invest. 94, 1310-1319.
30. Smith, C.A., Farrah, T., and Goodwin, R.G. (1994). The TNF receptor superfamily of cellular and viral proteins: activation, costimulation, and death. Cell 76, 959-962.
31. Soriano, P., Montgomery, C., Geske, R., and Bradley, A. (1991). Targeted disruption of the c-src proto-oncogene leads to osteopetrosis in mice. Cell 64, 693-702.
32. Suda, T., Takahashi, N., and Martin, T.J. (1992). Modulation of osteoclast differentiation. Endocrine Rev. 13, 66-80.
33. Tabas, J.A., Zasloff, M., Wasmuth, J.J., Emanuel, B.S., Altherr, M.R., McPherson, J.D., Wozney, J.M., and Kaplan, F.S. (1991). Bone morphogenetic protein: chromosomal localization of human genes for BMP1, BMP2A, and BMP3. Genomics 9, 283-289.
34. Thomson, B.M., Mundy, G.R., and Chambers, T.J. (1987). Tumor necrosis factor α and β induce osteoblastic cells to stimulate osteoclastic bone resorption. J. Immunol. 138, 775-779.
35. Udagawa, N., Takahashi, N., Akatsu, T., Sasaki, T., Yamaguchi, A., Kodama, H., Martin, T.J., and Suda, T. (1989). The bone marrow-derived stromal cells line MC3T3/PA6 and ST2 support osteoclast-like cell differentiation in cocultures with mouse spleen cells. Endocrinology 125, 1805-1813.
36. Wang, Z.-Q., Ovitt, C., Grigoriadis, A.E., Möhle-Steinlein, U., Rüther, U., and Wagner, E.F. (1992). Bone and haematopoietic defects in mice lacking c-Fos. Nature 360, 741-745.
37. Wronski, T.J., Dann, L.M., Scott, K.S., and Crooke, L.R. (1989). Endocrine and pharmacological suppressors of bone turnover protect against osteopeniain ovariectomized rats. Endocrinology 125, 810-816.
38. Yoshida, H., Hayashi, S., Kunisada, T., Ogawa, M., Nishikawa, S., Okumura, H., Sudo, T., Shultz, L.D., and Nishikawa, S.-I. (1990). The murine mutation osteopetrosis is in the coding region of the macrophage colony stimulating factor gene. Nature 345, 442-444.